glp-1 chemical structure Full-length human receptor without orthosteric ligands GLP-1s and beyond: Precision flow

Baggio LD

Final approval: FDA issues a formal decision

The right consumer research is critical to understanding these shifts and enabling companies to deliver healthier, more functional products that meet this growing demand. A complete representation of the Impact of GLP-1 on Food Choices can be found here

Aleix Cases declares having received a grant, consulting and speaking fees from Vifor Pharma, speaking and consulting fees from Astellas, Astra Zeneca, Bayer and Novo Nordisk

There is no clinical evidence that this patch provides the same therapeutic benefits as injectable GLP-1 agonists like Ozempic or Wegovy